$NVCR
NovoCure Ltd Stock $nvcr

$nvcr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000164511321000061 Filed on April 29, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$134.7M	$101.8M
YoY Change	32.28%	38.9%
Cost Of Revenue	$26.39M	$24.50M
YoY Change	7.71%	23.63%
Gross Profit	$108.3M	$77.33M
YoY Change	40.06%	44.56%
Gross Profit Margin	80.41%	75.94%
Selling, General & Admin	$62.48M	$55.44M
YoY Change	12.7%	30.23%
% of Gross Profit	57.69%	71.69%
Research & Development	$45.92M	$25.27M
YoY Change	81.69%	48.29%
% of Gross Profit	42.39%	32.68%
Depreciation & Amortization	$2.370M	$1.890M
YoY Change	25.4%	-2.07%
% of Gross Profit	2.19%	2.44%
Operating Expenses	$108.4M	$80.71M
YoY Change	34.3%	35.39%
Operating Profit	-$88.00K	-$3.381M
YoY Change	-97.4%	-44.74%
Interest Expense	-$2.600M	-$2.400M
YoY Change	8.33%	0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.734M	-$5.813M
YoY Change	-52.97%	-31.52%
Income Tax	$1.394M	-$9.765M
% Of Pretax Income
Net Earnings	-$4.128M	$3.952M
YoY Change	-204.45%	-132.53%
Net Earnings / Revenue	-3.06%	3.88%
Basic Earnings Per Share	-$0.04	$0.04
Diluted Earnings Per Share	-$0.04	$0.04
COMMON SHARES
Basic Shares Outstanding	102.6M shares	99.88M shares
Diluted Shares Outstanding	102.6M shares	108.1M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$864.4M	$331.3M
YoY Change	160.91%	29.11%
Cash & Equivalents	$314.5M	$181.9M
Short-Term Investments	$549.9M	$149.3M
Other Short-Term Assets	$11.40M	$800.0K
YoY Change	1325.0%	-61.9%
Inventory	$27.97M	$22.50M
Prepaid Expenses
Receivables	$92.51M	$65.14M
Other Receivables	$18.90M	$42.50M
Total Short-Term Assets	$1.015B	$462.2M
YoY Change	119.66%	37.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.73M	$9.778M
YoY Change	19.99%	-66.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.79M	$4.824M
YoY Change	123.63%	-3.52%
Total Long-Term Assets	$52.39M	$40.27M
YoY Change	30.11%	16.39%
TOTAL ASSETS
Total Short-Term Assets	$1.015B	$462.2M
Total Long-Term Assets	$52.39M	$40.27M
Total Assets	$1.068B	$502.4M
YoY Change	112.49%	35.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$52.70M	$40.40M
YoY Change	30.45%	35.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$110.5M	$84.20M
YoY Change	31.22%	18.76%
LONG-TERM LIABILITIES
Long-Term Debt	$559.6M	$149.5M
YoY Change	274.39%	0.11%
Other Long-Term Liabilities	$177.0K	$267.0K
YoY Change	-33.71%	-98.87%
Total Long-Term Liabilities	$585.0M	$176.3M
YoY Change	231.83%	1.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$110.5M	$84.20M
Total Long-Term Liabilities	$585.0M	$176.3M
Total Liabilities	$695.5M	$260.5M
YoY Change	166.99%	6.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$631.7M	-$646.9M
YoY Change	-2.35%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$372.1M	$241.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.068B	$502.4M
YoY Change	112.49%	35.69%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$4.128M	$3.952M
YoY Change	-204.45%	-132.53%
Depreciation, Depletion And Amortization	$2.370M	$1.890M
YoY Change	25.4%	-2.07%
Cash From Operating Activities	$17.78M	$1.957M
YoY Change	808.53%	-145.35%
INVESTING ACTIVITIES
Capital Expenditures	$3.981M	$3.112M
YoY Change	27.92%	33.85%
Acquisitions
YoY Change
Other Investing Activities	$58.15M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$54.17M	-$3.112M
YoY Change	-1840.71%	214.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change
Debt Paid & Issued, Net	$6.000K	$8.000K
YoY Change	-25.0%	0.0%
Cash From Financing Activities	$7.955M	$4.503M
YoY Change	76.66%	-73.46%
NET CHANGE
Cash From Operating Activities	$17.78M	$1.957M
Cash From Investing Activities	$54.17M	-$3.112M
Cash From Financing Activities	$7.955M	$4.503M
Net Change In Cash	$79.80M	$3.289M
YoY Change	2326.39%	-71.16%
FREE CASH FLOW
Cash From Operating Activities	$17.78M	$1.957M
Capital Expenditures	$3.981M	$3.112M
Free Cash Flow	$13.80M	-$1.155M
YoY Change	-1294.72%	-82.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001645113
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-37565
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	NovoCure Limited
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1057807
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 4 The Forum
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Grenville Street
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Helier
CY2021Q1	dei	Entity Address Country EntityAddressCountry	JE
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	JE2 4UF
CY2021Q1	dei	City Area Code CityAreaCode	44 (0) 15
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	3475 6700
CY2021Q1	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value
CY2021Q1	dei	Trading Symbol TradingSymbol	NVCR
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	103413367	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	314547000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	234674000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	549855000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	607902000	USD
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	11430000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11499000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	92514000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	96699000	USD
CY2021Q1	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	18922000	USD
CY2020Q4	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	21245000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	27968000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	27422000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	1015236000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	999441000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11733000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11395000	USD
CY2021Q1	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	12132000	USD
CY2020Q4	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	11230000	USD
CY2021Q1	us-gaap	Assets Assets	1067630000	USD
CY2020Q4	us-gaap	Assets Assets	1051983000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9577000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17741000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19009000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10788000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10908000	USD
CY2021Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	52394000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	52542000	USD
CY2021Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	52703000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	53647000	USD
CY2021Q1	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	57784000	USD
CY2020Q4	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	59965000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	110487000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	113612000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	559584000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	429905000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	461845000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	12139000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12708000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14293000	USD
CY2021Q1	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	2963000	USD
CY2020Q4	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	5171000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	177000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	337000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	585009000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	695496000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	575457000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	103187460	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103187460	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102334276	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102334276	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1005785000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1111435000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1948000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3832000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-631703000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-631077000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	372134000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	476526000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1067630000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1051983000	USD
CY2021Q1	us-gaap	Revenues Revenues	134695000	USD
CY2020Q1	us-gaap	Revenues Revenues	101828000	USD
CY2020	us-gaap	Revenues Revenues	494366000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	26385000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	24496000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	106501000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	108310000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	77332000	USD
CY2020	us-gaap	Gross Profit GrossProfit	387865000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45916000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25271000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	132010000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	31357000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28834000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	118017000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31125000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26608000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107437000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	108398000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	80713000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	357464000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-88000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3381000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	30401000	USD
CY2021Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2646000	USD
CY2020Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2432000	USD
CY2020	us-gaap	Interest And Debt Expense InterestAndDebtExpense	12299000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2734000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5813000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18102000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1394000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9765000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1706000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	19808000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102633545	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99877567	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100930866	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102633545	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108100623	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108877648	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	19808000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	980000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-268000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-200000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-85000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2152000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	662000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2244000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3090000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18743000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	476526000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18863000	USD
CY2021Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	7961000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1884000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	372134000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	217790000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16557000	USD
CY2020Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	4511000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-862000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	241948000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	19808000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2370000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1888000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9150000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	176000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	429000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18863000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16557000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	75721000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2157000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	699000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4624000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19718000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30354000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	603000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-539000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3260000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1296000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1147000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2935000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1432000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1235000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1366000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2626000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2339000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	25470000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4394000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-225000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	664000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17780000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1957000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	99148000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3981000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3112000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14968000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	608000000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	150000000	USD
CY2021Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	549848000	USD
CY2020Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	607879000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54171000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3112000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-472847000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3370000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	558439000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	150028000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7961000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4511000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28428000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7955000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4503000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	440209000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-102000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-59000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	247000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	79804000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3289000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	66757000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246173000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	325977000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	3415000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	8686000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182705000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246173000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2405000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2209000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3261000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	284000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	783000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5617000	USD
CY2021Q1	us-gaap	Cash Cash	31849000	USD
CY2020Q4	us-gaap	Cash Cash	20339000	USD
CY2021Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	282698000	USD
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	214335000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	314547000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	234674000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	549855000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	607902000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	549890000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	607905000	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3376000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5175000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9342000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4896000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15250000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17351000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	27968000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	27422000	USD
CY2021Q1	us-gaap	Deposits Assets DepositsAssets	1409000	USD
CY2020Q4	us-gaap	Deposits Assets DepositsAssets	1438000	USD
CY2021Q1	us-gaap	Contractual Obligation ContractualObligation	1649000	USD
CY2020Q4	us-gaap	Contractual Obligation ContractualObligation	1687000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9220326	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.21
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	375689	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	153.09
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	404591	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.36
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20911	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	62.86
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9170513	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.63
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5344848	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.59
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	404591	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18863000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16557000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	75721000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	19808000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4128000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3952000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	19808000	USD
CY2021Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2020Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2020	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4128000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3952000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19808000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102633545	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99877567	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100930866	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102633545	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108100623	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108877648	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9734269	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	352291	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1307762	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2021Q1	us-gaap	Noncurrent Assets NoncurrentAssets	23865000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	22625000	USD
CY2021Q1	us-gaap	Revenues Revenues	134695000	USD
CY2020Q1	us-gaap	Revenues Revenues	101828000	USD
CY2020	us-gaap	Revenues Revenues	494366000	USD

Files In Submission

Name	View Source	Status
0001645113-21-000061-index-headers.html	Edgar Link	pending
0001645113-21-000061-index.html	Edgar Link	pending
0001645113-21-000061.txt	Edgar Link	pending
0001645113-21-000061-xbrl.zip	Edgar Link	pending
ex101longsworthemploymenta.htm	Edgar Link	pending
ex102non-employeedirectorc.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvcr-20210331.htm	Edgar Link	pending
nvcr-20210331.xsd	Edgar Link	pending
nvcr-20210331xexx311.htm	Edgar Link	pending
nvcr-20210331xexx312.htm	Edgar Link	pending
nvcr-20210331xexx321.htm	Edgar Link	pending
nvcr-20210331xexx322.htm	Edgar Link	pending
nvcr-20210331_cal.xml	Edgar Link	unprocessable
nvcr-20210331_def.xml	Edgar Link	unprocessable
nvcr-20210331_g1.jpg	Edgar Link	pending
nvcr-20210331_htm.xml	Edgar Link	completed
nvcr-20210331_lab.xml	Edgar Link	unprocessable
nvcr-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVCR
NovoCure Ltd Stock $nvcr

2021 Q1 Form 10-Q Financial Statement

#000164511321000061 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR NovoCure Ltd Stock $nvcr

2021 Q1 Form 10-Q Financial Statement

#000164511321000061 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR
NovoCure Ltd Stock $nvcr